Revenue

Health Canada's Priority Review for a new Duchenne muscular dystrophy drug signals hope for patients and a strategic test of Canada's rare disease market.

A UK firm's regulatory milestone is more than just compliance; it's a strategic masterclass in building the resilient systems needed to fight food allergies.

Questex's Fierce Biotech is launching a UK event, but this is more than expansion. It’s a calculated bet on London's future as a biotech superpower.

A groundbreaking partnership between Servier and n-Lorem Foundation blends pharma R&D muscle with non-profit agility to develop ASO therapies for the rarest of diseases.

A landmark deal locks in energy for Ukraine and Finland until 2044, cementing a small Baltic terminal as a powerhouse of European strategic resilience.

A new campaign pairs a star athlete with a robotic mower, revealing a deeper strategy to win the multi-billion-dollar race for autonomous home care.

A new study by SciBase and Castle Biosciences is testing technology to predict atopic dermatitis flares, promising a shift from reactive care to patient control.

A global health giant is now targeting the world's financial system, arguing that crippling debt is a deadlier crisis than any disease. Is their plan a revolution or a fantasy?

In just two years, AIKO Energy has captured a significant slice of Australia's solar market. We dissect the strategy combining breakthrough tech and local focus.

Sanofi's promising nerve disease drug fails in late-stage trials, leaving vulnerable patients in limbo and highlighting the brutal realities of medical innovation.

A new routing model promises to solve the persistent liquidity and execution problems plaguing the $31B tokenized asset market. Is this the key?

Akkodis is betting on 3D-printed wings and AI-powered inspections to make existing aircraft fleets greener, safer, and more efficient.

As illicit tobacco and vapes flood India, Big Tobacco calls for a crackdown. But is this a genuine partnership or a strategic play in a global shadow economy?

ERock hits the NYSE, selling investors on a solution to the AI energy crisis. But with steep losses and regulatory hurdles, its future is far from guaranteed.

The newly formed SPAC, led by veterans of sports finance and investment banking, is targeting acquisitions in sports, eSports, and entertainment.

Imagine's appointment of Mike Ritzenthaler isn't just a new hire; it's a calculated move to fuel growth. His track record signals a major financial overhaul.

Guangzhou's top arbitration court opens a Singapore office, a strategic move to serve the Belt and Road and reshape Asia's dispute resolution landscape.

A major acquisition in retail services signals a seismic shift. Discover how Agility Retail and The Marco Company are redesigning the future of physical stores.

Takeda seeks FDA approval for its gut-focused drug ENTYVIO in children, a major step toward a new era of treatment for the rising tide of pediatric IBD.

Snap-on's acquisition of Diesel Laptops for $100M is more than a tool deal; it's a strategic move to dominate the complex, data-rich heavy-duty diagnostics market.